Current Report Filing (8-k)
November 06 2019 - 3:41PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington,
DC 20549
_________________
FORM 8-K
_________________
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities Exchange Act of 1934
November 6,
2019
Date of Report (date of earliest event reported)
_________________
OpGen, Inc.
(Exact name
of Registrant as specified in its charter)
_________________
Delaware
(State
or other jurisdiction of incorporation or organization)
|
|
001-37367
(Commission
File
Number)
|
|
06-1614015
(I.R.S.
Employer
Identification Number)
|
708
Quince Orchard Road, Suite 205
Gaithersburg, MD 20878
(Address of principal executive offices)
(240)
813-1260
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
_________________
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (see General Instruction A.2. below):
[_] Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[_] Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[_] Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[_] Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b)
of the Act:
|
Title
of Each Class
|
Trading Symbol
|
Name of Each Exchange on Which Registered
|
Common Stock
|
OPGN
|
The Nasdaq Capital
Market
|
Common Warrants
|
OPGNW
|
The Nasdaq Capital
Market
|
Indicate by check mark whether
the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter)
or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company [X]
If an emerging growth company,
indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised
financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [_]
Item 2.02 Results of Operations
and Financial Condition.
On November 6, 2019, OpGen, Inc.
issued a press release announcing its financial results for the quarter ended September 30, 2019. The full text of such press
release is furnished as Exhibit 99.1 to this report.
Item
9.01 Financial Statements and Exhibits.
(d) Exhibits
The
information included herein and in Exhibit 99.1 shall not be deemed “filed” for purposes of Section 18 of the Securities
Exchange Act of 1934 (“Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed
incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by
specific reference in such filing.
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.
Date: November 6, 2019
|
OpGen, Inc.
|
|
|
|
By:
|
/s/ Timothy C. Dec
|
|
|
Timothy C. Dec
Chief Financial
Officer
|
OpGen (NASDAQ:OPGN)
Historical Stock Chart
From Aug 2024 to Sep 2024
OpGen (NASDAQ:OPGN)
Historical Stock Chart
From Sep 2023 to Sep 2024